Literature DB >> 16402898

Cytochrome P450 and xenobiotic receptor humanized mice.

Frank J Gonzalez1, Ai-Ming Yu.   

Abstract

Most xenobiotics that enter the body are subjected to metabolism that functions primarily to facilitate their elimination. Metabolism of certain xenobiotics can also result in the production of electrophilic derivatives that can cause cell toxicity and transformation. Many xenobiotics can also activate receptors that in turn induce the expression of genes encoding xenobiotic-metabolizing enzymes and xenobiotic transporters. However, there are marked species differences in the way mammals respond to xenobiotics, which are due in large part to molecular differences in receptors and xenobiotic-metabolizing enzymes. This presents a problem in extrapolating data obtained with rodent model systems to humans. There are also polymorphisms in xenobiotic-metabolizing enzymes that can impact drug therapy and cancer susceptibility. In an effort to generate more reliable in vivo systems to study and predict human response to xenobiotics, humanized mice are under development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16402898      PMCID: PMC1440291          DOI: 10.1146/annurev.pharmtox.45.120403.100007

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  141 in total

Review 1.  The AH-receptor: genetics, structure and function.

Authors:  H I Swanson; C A Bradfield
Journal:  Pharmacogenetics       Date:  1993-10

Review 2.  Regulation of cytochrome P450 genes: molecular mechanisms.

Authors:  F J Gonzalez; S Y Liu; M Yano
Journal:  Pharmacogenetics       Date:  1993-02

3.  A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements.

Authors:  M Baes; T Gulick; H S Choi; M G Martinoli; D Simha; D D Moore
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

Review 4.  Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins.

Authors:  F J Gonzalez; H V Gelboin
Journal:  Drug Metab Rev       Date:  1994       Impact factor: 4.518

5.  cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor.

Authors:  T Sher; H F Yi; O W McBride; F J Gonzalez
Journal:  Biochemistry       Date:  1993-06-01       Impact factor: 3.162

6.  Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer.

Authors:  I Persson; I Johansson; H Bergling; M L Dahl; J Seidegård; R Rylander; A Rannug; J Högberg; M I Sundberg
Journal:  FEBS Lett       Date:  1993-03-22       Impact factor: 4.124

7.  Replacement of Thr-303 of P450 2E1 with serine modifies the regioselectivity of its fatty acid hydroxylase activity.

Authors:  T Fukuda; Y Imai; M Komori; M Nakamura; E Kusunose; K Satouchi; M Kusunose
Journal:  J Biochem       Date:  1993-01       Impact factor: 3.387

8.  Nuclear uptake of the Ah (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene.

Authors:  L C Quattrochi; R H Tukey
Journal:  Mol Pharmacol       Date:  1993-04       Impact factor: 4.436

9.  Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.

Authors:  I Johansson; E Lundqvist; L Bertilsson; M L Dahl; F Sjöqvist; M Ingelman-Sundberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1.

Authors:  R M Laethem; M Balazy; J R Falck; C L Laethem; D R Koop
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

View more
  42 in total

1.  A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4.

Authors:  Xiaochao Ma; Connie Cheung; Kristopher W Krausz; Yatrik M Shah; Ting Wang; Jeffrey R Idle; Frank J Gonzalez
Journal:  Drug Metab Dispos       Date:  2008-09-17       Impact factor: 3.922

Review 2.  Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery.

Authors:  Yue-Zhong Shu; Benjamin M Johnson; Tian J Yang
Journal:  AAPS J       Date:  2008-03-13       Impact factor: 4.009

3.  Antiproliferative and apoptotic-inducing potential of ellagic acid against 1,2-dimethyl hydrazine-induced colon tumorigenesis in Wistar rats.

Authors:  Syed Umesalma; Ponnuraj Nagendraprabhu; Ganapasam Sudhandiran
Journal:  Mol Cell Biochem       Date:  2013-11-27       Impact factor: 3.396

Review 4.  Indolealkylamines: biotransformations and potential drug-drug interactions.

Authors:  Ai-Ming Yu
Journal:  AAPS J       Date:  2008-05-03       Impact factor: 4.009

5.  Global patterns of variation in allele and haplotype frequencies and linkage disequilibrium across the CYP2E1 gene.

Authors:  M-Y Lee; N Mukherjee; A J Pakstis; S Khaliq; A Mohyuddin; S Q Mehdi; W C Speed; J R Kidd; K K Kidd
Journal:  Pharmacogenomics J       Date:  2008-07-29       Impact factor: 3.550

6.  Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model.

Authors:  Chao Wu; Xi-Ling Jiang; Hong-Wu Shen; Ai-Ming Yu
Journal:  Biochem Pharmacol       Date:  2009-05-13       Impact factor: 5.858

7.  A human hepatocyte-bearing mouse: an animal model to predict drug metabolism and effectiveness in humans.

Authors:  Katsutoshi Yoshizato; Chise Tateno
Journal:  PPAR Res       Date:  2009-10-26       Impact factor: 4.964

8.  Species differences in the pharmacokinetics of cefadroxil as determined in wildtype and humanized PepT1 mice.

Authors:  Yongjun Hu; David E Smith
Journal:  Biochem Pharmacol       Date:  2016-03-12       Impact factor: 5.858

9.  Gene expression profiling in male B6C3F1 mouse livers exposed to kava identifies--changes in drug metabolizing genes and potential mechanisms linked to kava toxicity.

Authors:  Lei Guo; Qiang Shi; Stacey Dial; Qingsu Xia; Nan Mei; Quan-zhen Li; Po-Chuen Chan; Peter Fu
Journal:  Food Chem Toxicol       Date:  2009-12-03       Impact factor: 6.023

10.  Cytochrome-P450 enzymes and autoimmunity: expansion of the relationship and introduction of free radicals as the link.

Authors:  M R Namazi
Journal:  J Autoimmune Dis       Date:  2009-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.